RxDoctor Payments Data

Louis Forouhar-Graff, MD

Psychiatry · Hartford, CTNPI 1760794820

Payments from drug & device makers

$529in general payments, 2019–2025

Across 26 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$149
  • Indivior Inc.$131
  • E.r. Squibb & Sons, L.L.C.$94
  • Teva Pharmaceuticals USA, Inc.$41
  • Corium, LLC$34
  • Lundbeck LLC$26
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$48592%
  • Education$448%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$529 in reported general payments places this provider in the 70th percentile of 644 psychiatry providers in Connecticut.

See all psychiatry providers in Connecticut

Medicare billing

Part B allowed, 2024
$31,689
Medicare patients
81
Services billed
380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate28$230,426
AustedoDeutetrabenazine11$69,632
RexultiBrexpiprazole36$65,296
Austedo XrDeutetrabenazine13$62,316
LatudaLurasidone Hcl12$31,562
TrintellixVortioxetine Hydrobromide28$25,541
VivitrolNaltrexone Microspheres14$23,582
Aripiprazole150$21,287
Lurasidone Hcl82$8,722
Bupropion XlBupropion Hcl295$7,460
VyvanseLisdexamfetamine Dimesylate14$6,889
Desvenlafaxine Succinate ErDesvenlafaxine Succinate50$6,528
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine161$5,640
Gabapentin158$3,996
Clomipramine Hcl18$3,982

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$25$230,42628 claims
Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr$41$131,94824 claims
Otsuka America Pharmaceutical, Inc.Rexulti$18$65,29636 claims
Alkermes, Inc.Vivitrol$11$23,58214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 644 psychiatry providers in Connecticut.

Other psychiatry in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →